Skip to content

Clinical trials

Atherosclerosis trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Country / region: Spain Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20053
20082
20093
20101
20113
20121
20131
20142
20152
20162
20172
20184
20191
20204
20211
20224
20231
20247
20257
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Active, not recruiting12
Recruiting9
Unknown status5
Not yet recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
Eli Lilly and Company4
Amgen3
AstraZeneca3
Boston Scientific Corporation3
Milagros Rocha Barajas3
Novartis Pharmaceuticals3
Biotronik AG2
CSL Behring2
University of Valencia2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis58
Cardiovascular Diseases17
Coronary Artery Disease9
Acute Coronary Syndrome6
Inflammation6
Coronary Disease5
Heart Diseases5
Peripheral Arterial Disease5
Obesity4
Arteriosclerosis3

Trials

Showing 26 to 50 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.